Contineum Therapeutics (CTNM) Change in Acquisitions & Divestments (2023 - 2025)
Historic Change in Acquisitions & Divestments for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $33.7 million.
- Contineum Therapeutics' Change in Acquisitions & Divestments fell 2034.81% to $33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.8 million, marking a year-over-year increase of 1636.58%. This contributed to the annual value of $157.2 million for FY2024, which is 10487.28% up from last year.
- Contineum Therapeutics' Change in Acquisitions & Divestments amounted to $33.7 million in Q3 2025, which was down 2034.81% from $39.4 million recorded in Q2 2025.
- In the past 5 years, Contineum Therapeutics' Change in Acquisitions & Divestments ranged from a high of $48.7 million in Q1 2025 and a low of $12.6 million during Q3 2023
- In the last 3 years, Contineum Therapeutics' Change in Acquisitions & Divestments had a median value of $33.7 million in 2025 and averaged $32.3 million.
- Per our database at Business Quant, Contineum Therapeutics' Change in Acquisitions & Divestments surged by 23553.4% in 2024 and then crashed by 2034.81% in 2025.
- Quarter analysis of 3 years shows Contineum Therapeutics' Change in Acquisitions & Divestments stood at $31.3 million in 2023, then surged by 44.03% to $45.1 million in 2024, then fell by 25.37% to $33.7 million in 2025.
- Its Change in Acquisitions & Divestments was $33.7 million in Q3 2025, compared to $39.4 million in Q2 2025 and $48.7 million in Q1 2025.